Key Highlights
- Nebius Group (NBIS) climbed 11.8% to close at $154.49 on Friday, reaching an intraday peak of $156.00
- The company announced plans to purchase Eigen AI for approximately $643 million through a combination of cash and equity
- This acquisition targets enhancement of Nebius’ AI inference capabilities while expanding operations in California’s Bay Area
- Wall Street consensus shows a “Moderate Buy” rating with an average price target of $154.75
- First quarter 2026 financial results will be released May 13 during pre-market hours
Nebius Group (NBIS) experienced significant upward momentum on Friday, gaining 11.8% and reaching an intraday high of $156.00 before closing at $154.49. Trading volume reached approximately 15.7 million shares, marginally exceeding typical daily levels.
The primary driver behind this surge was the company’s announcement of its intent to purchase Eigen AI for roughly $643 million, structured as a combination of cash and stock.
Eigen AI specializes in inference technology and post-training optimization solutions. Nebius intends to integrate these advanced capabilities into its existing Nebius Token Factory platform, which handles production-level AI workload management.
The transaction is anticipated to finalize within the next several weeks, subject to customary closing conditions including regulatory antitrust approval.
Beyond technological advantages, Nebius highlighted that this acquisition could significantly strengthen its presence across U.S. markets. The founding team from Eigen AI is expected to establish and lead an engineering and research hub located in the San Francisco Bay Area.
Equity options trading patterns also contributed to the stock’s momentum. Traders purchased approximately 130,000 call contracts during Friday’s session — roughly 23% higher than typical levels — reflecting heightened speculative positioning around upcoming corporate events.
A widespread rally across technology sectors provided additional tailwinds. AI-focused companies and cloud infrastructure providers experienced broad gains as the Nasdaq index advanced.
Wall Street Perspective
Analyst opinions on NBIS show a cautiously optimistic stance. The consensus recommendation sits at “Moderate Buy” with an average price objective of $154.75, closely aligned with Friday’s closing price.
DA Davidson maintains the highest conviction with a $200.00 price target, while Morgan Stanley takes a more conservative approach with an “equal weight” designation and a $126.00 target. Bank of America and Compass Point both maintain “buy” recommendations with identical $150.00 price objectives.
Executive Transactions and Financial Metrics
Recent insider activity shows two executives divested shares during mid-April. Director Elena Bunina disposed of 6,250 shares at a price of $161.22, while CRO Marc Boroditsky sold 4,500 shares at $160.10. Both transactions occurred through pre-established 10b5-1 trading arrangements.
Aggregate insider selling reached approximately 129,740 shares valued at more than $14.6 million throughout the most recent quarter.
Financial performance metrics present ongoing challenges. Nebius fell short of earnings per share projections in its most recent quarterly report, recording a loss of $0.69 per share compared to analyst expectations of -$0.42. Revenue totaled $227.7 million, undershooting the consensus estimate of $246 million.
The company currently trades at a P/E ratio of -105.82 and carries a beta coefficient of 4.20, indicating substantial volatility and elevated risk characteristics. Full-year analyst projections anticipate a loss of $2.44 per share.
Technical indicators show the stock’s 50-day moving average positioned at $120.73 with the 200-day moving average at $106.24, placing Friday’s closing price meaningfully above both key trend levels.
Institutional ownership accounts for approximately 21.9% of outstanding shares.
The company will report first quarter 2026 financial results on May 13 during pre-market trading hours.
